Ltd. "Fort" begins construction in the village Yaltunovo Ryazan region of the pharmaceutical industrial complex, the relevant international standard GMP.
The new plant will produce on the basis of bio-and nanotechnology medicines for the treatment of infectious and somatic diseases. Drug development was carried out by scientists and specialists of the enterprise together with leading scientific centers of the Russian Academy of Medical Sciences.
Under the instructions of the President of the Government of the Russian Federation VV Putin’s Ministry of Industry and Trade and the Ministry of Health and Social Development Ministry is working on the inclusion of the object in the Register of promising projects in the pharmaceutical and medical industries. Order of the Government of Ryazan Region decided to provide state support for the project, LLC "Fort", which signed an investment agreement providing for the provision of a number of tax benefits and preferences.
The project is funded under an agreement Ltd. "Fort" with the State Corporation "Bank for Development and Foreign Economic Affairs". Investment of over 4.8 billion rubles. The enterprise is planned for 2013, the output of the production capacity is planned for 2015.
The commissioning of the plant will create more than 1,000 new jobs. Recruitment companies will be from among the graduates of the State Medical University. Academician Ivan Pavlova (pharmaceutical and medical-prophylactic faculty), and the Ryazan State University. SA Esenina (equipment specialist engineering majors).
The Governor Oleg Kovalyov said: "The project is implemented by LLC" FORT ", is the most ambitious in recent years to establish in Russia the production of the latest medical biotech drugs. In terms of technology and scale of production, he will become one of the leading not only in Russia but also in Europe. "